Bio-Reference Laboratories Inc.’s (BRLI) share price has entered into oversold territory with a stochastic value of 17.5491. The Zacks Consensus Estimate on the company’s earnings for year ending October 2013 increased by a cent over the past two months to $1.76 per share. Bio-Reference Laboratories Inc. is a Zacks Rank #2 (“Buy”) company.
More From Zacks.com
- Investment & Company Information